The GLISTEN trial of GSK's linerixibat has shown that the oral ileal bile acid transporter (IBAT inhibitor was signposted as ...

Biomedical research in liver diseases has traditionally depended on animal models, but ethical concerns and the quest for ...

The publication reports results from the 96-week SYMMETRY study evaluating the efficacy and safety of Akero's lead FGF21 ...

ThAIG hospital removes kidney tumor of a patient with chronic liver diseasee growing importance of minimally invasive robotic ...